US EditionSeveral dead birds found in Oak Creek add to concern over bird flu
- The FDA has fast-tracked ARCT-2304, an mRNA vaccine for H5N1 avian influenza, according to a statement from Arcturus Therapeutics on April 10.
- Over 70 people in the U.S. Have contracted H5N1 avian influenza this year, resulting in one death, according to the CDC.
- Despite the low current public health risk reported by the CDC, significant public concern exists regarding the vaccine's safety and transparency.
- The vaccine project is funded by the Department of Health and Human Services, reflecting efforts to prepare for potential health crises.
11 Articles
11 Articles
Trump Administration Fast-Tracks Controversial Self-Amplifying mRNA Vaccine for H5N1 Bird Flu
The Trump administration announced its decision to grant Fast Track designation to ARCT-2304, a self-amplifying mRNA (sa-mRNA) vaccine candidate developed by Arcturus Therapeutics targeting the H5N1 avian influenza virus. This move has sparked significant debate, with proponents highlighting its potential to bolster pandemic preparedness and critics raising concerns about safety and transparency. ARCT-2304 differs from […]
Trump Administration Accelerates Self-Amplifying Bird Flu Vaccine With Fast Track Approval
from Your News: The ARCT-2304 vaccine, funded by BARDA and based on self-replicating mRNA, is undergoing expedited review amid pandemic preparedness efforts. By yourNEWS Media Newsroom The Trump administration has granted Fast Track designation to a self-amplifying mRNA vaccine for H5N1 avian influenza, marking a significant move in pandemic preparedness policy. The vaccine, ARCT-2304, developed […]
Here We Go Again: FDA Grants Fast-Track Designation for Possible mRNA Bird Flu "Vaccine" - 🔔 The Liberty Daily
(The Epoch Times)—The Food and Drug Administration (FDA) moved last week to fast-track an mRNA vaccine candidate for a type of avian influenza, or bird flu, that has sickened more than 70 Americans this year, according to the company that developed the vaccine. Arcturus Therapeutics said in an April 10 statement that the vaccine, ARCT-2304, is now in its Phase 1 trials. “We are pleased to receive fast-track designation from the FDA for ARCT-2304…
America First Report
Uncanceled NewsHere We Go Again: FDA Grants Fast-Track Designation for Possible mRNA Bird Flu “Vaccine”
(The Epoch Times)—The Food and Drug Administration (FDA) moved last week to fast-track an mRNA vaccine candidate for a type of avian influenza, or bird flu, that has sickened more than 70 Americans this year, according to the company that developed the vaccine. Arcturus Therapeutics said in an April 10 statement that the vaccine, ARCT-2304, is now in its Phase 1 trials. “We are pleased to receive fast-track designation from the FDA for ARCT-2304…
Several dead birds found in Oak Creek add to concern over bird flu
A beach just north of the South Shore Wastewater Treatment Plant is the latest setting of growing concern over Avian Influenza in Milwaukee County and around the state. RELATED CONTENT: We Energies' longest-returning peregrine falcons have died, likely from bird fluThe beach became more easily accessible this month with the South Metro Fishing Pier opening up it's gates, which leads down to the beach."So this last Saturday the beach was open," s…
FDA Grants Fast-Track Designation for Possible mRNA Bird Flu Vaccine, Company Says
The Food and Drug Administration (FDA) moved last week to fast-track an mRNA vaccine candidate for a type of avian influenza, or bird flu, that has sickened more than 70 people in the United States this year, according to the company that developed the vaccine. Arcturus Therapeutics said in an April 10 statement that the vaccine, ARCT-2304, is now in its Phase 1 trials. “We are pleased to receive fast-track designation from the FDA for ARCT-2304…
Coverage Details
Bias Distribution
- 88% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
